After listing on the Nasdaq market on May 18, Hong Kong-based diagnostics and genetic testing company Prenetics Group Ltd. saw its shares fall nearly 30% in early trading, dropping from $8.40 per share on listing to $5.70 by the end of trading May 19. Trading under the ticker PRE, Prenetics formed a merger with Artisan Acquisition Corp., a special purpose acquisition company, which was founded by entrepreneur Adrian Cheng. The transaction values Prenetics at an enterprise value of $1.25 billion, making the company the first Hong Kong unicorn to list on the Nasdaq.

Med-tech firms raising money in public or private financings, including: Babylon.

Biopharmas raising money in public or private financings, including: Cinclus, Evofem, Hemostemix, Okyo.

Med-tech firms raising money in public or private financings, including: Apiject Systems, Deciphex, Eurobio Scientific, Predictive Oncology.

Biopharmas raising money in public or private financings, including: Appili, Baudax, Celularity, Laekna, Locus, Tenax.

An unknown U.K. biotech, RQ Biotechnology Ltd., has emerged from stealth mode with a $157 million licensing deal with Astrazeneca plc for its monoclonal antibodies, aimed at protecting vulnerable and immunosuppressed people against SARS-CoV-2.

Med-tech firms raising money in public or private financings, including: Mirvie, Vivasure Medical.